Kelly CRISPR & Gene Editing Technology ETF

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

Jurisdiction: USLegal Form: 8888

ACTIVE

LEI: 54930008LLNT6JJ4MO84

Summary

Kelly CRISPR & Gene Editing Technology ETF is an organization. It is a subsidiary of Kelly CRISPR & Gene Editing Technology ETF. It has 1 known subsidiary.

Legal entity: GLEIF